Insulin Access Issues

The conversation highlights the alarming lack of diversity among insulin manufacturers and the dire consequences this has on patient access. Many diabetics remain unaware of the newer insulin types available, which can lead to dangerous situations. Additionally, the struggle for patients to advocate for themselves, often due to educational barriers and authority dynamics, complicates their ability to obtain necessary prescriptions and care.